Company Description
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body’s vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations.
It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter.
The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures.
Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
| Country | United States |
| Founded | 2010 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 43 |
| CEO | Harel Gadot |
Contact Details
Address: 175 Derby Street, Bld. 27 Hingham, Massachusetts 02043 United States | |
| Phone | 781 875 3605 |
| Website | microbotmedical.com |
Stock Details
| Ticker Symbol | MBOT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000883975 |
| CUSIP Number | 59503A204 |
| ISIN Number | US59503A2042 |
| Employer ID | 94-3078125 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Harel Gadot | Co-Founder, President, Chief Executive Officer and Chairman |
| Rachel Vaknin | Chief Financial Officer |
| Dr. Simon Sharon MBA, MSc | Chief Technology Officer and GM of Microbot Israel |
| Dr. Juan Diaz-Cartelle | Chief Medical Officer |
| Michal Ahuvia | Director of Operations |
| Christina Bailey | Vice President of Sales |
| Allison Rosefort | Vice President of Marketing |
| Naama Moav | Vice President of Human Resources |
| Michael Lytle | Head of Sales Operations and Analytics |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 22, 2026 | 8-K | Current Report |
| Apr 14, 2026 | 8-K | Current Report |
| Apr 13, 2026 | 8-K | Current Report |
| Apr 10, 2026 | 424B5 | Filing |
| Apr 10, 2026 | 8-K | Current Report |
| Mar 26, 2026 | 10-K | Annual Report |
| Mar 26, 2026 | 8-K | Current Report |
| Mar 24, 2026 | 8-K | Current Report |
| Mar 17, 2026 | 8-K | Current Report |
| Mar 10, 2026 | 8-K | Current Report |